Agri Business

Indian co in global team developing vaccine for cattle

Our Bureau Hyderabad | Updated on January 13, 2012 Published on January 13, 2012


Haemorrhagic septicaemia, a deadly bacterial disease that kills over 5 lakh cattle and buffalo in India, could soon be controlled. A consortium of global institutes, including Indian Immunologicals Ltd, have joined hands to develop a new vaccine over the next three years.

Current vaccines have achieved limited success in affording long-term protection. The new vaccine will be a genetically modified organism administered as vaccine. The consortia includes Inocul8 UK (the commercial interface of Moredun Research Institute, UK), Global Alliance for Veterinary Medicine (University of Glasgow, UK) and Indian Veterinary Research Institute.

The disease caused by the bacterium Pasteurella multocida has a major impact on the livestock industry in countries in south and southeast Asia. Young animals are at high risk.

Dr V.A. Srinivasan, Research Director at Indian Immunologicals, said, “An affordable, effective and improved vaccine for control of Haemorrhagic septicaemia is the need of the hour. The farming community will benefit immensely with the use of such a novel vaccine by preventing loss of animals due to the disease.”

The company is among India's top three animal-health players. It is among the few companies doing research to develop veterinary vaccines to address the needs of the livestock sector in the country.

[email protected]

Published on January 13, 2012
This article is closed for comments.
Please Email the Editor